PDCD1 and hereditary sensory and autonomic neuropathy: According to the World Health Organization Drug Alert database, of the 613 fatalities resulting from ICI treatment from 2018 to 2019, 35% of which were due to CIP caused by anti-PD-1/PD-L1 drugs 76.